Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 4Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Pancreatic Neoplasms 100Carcinoma, Non-Small-Cell Lung 48Neoplasms 34Urinary Bladder Neoplasms 25Lung Neoplasms 25Cholangiocarcinoma 23Breast Neoplasms 22Neoplasm Metastasis 21Ovarian Neoplasms 18Lymphoma, Non-Hodgkin 13Lymphoma 13Recurrence 12Lymphoma, Large B-Cell, Diffuse 11Biliary Tract Neoplasms 11Sarcoma 10Carcinoma, Transitional Cell 9Hodgkin Disease 8Gallbladder Neoplasms 8Fallopian Tube Neoplasms 8Adenocarcinoma 8Bile Duct Neoplasms 7Colorectal Neoplasms 6Triple Negative Breast Neoplasms 5Lymphoma, Follicular 5Liver Neoplasms 5Head and Neck Neoplasms 5Carcinoma, Renal Cell 5Adenocarcinoma of Lung 5Uterine Cervical Neoplasms 4Small Cell Lung Carcinoma 4

Interventions

Ifosfamide 4Paclitaxel 3Thiotepa 2Peripheral Blood Stem Cell Transplantation 2Flow Cytometry 2Filgrastim 2Cisplatin 2Carboplatin 2Amplified Fragment Length Polymorphism Analysis 2tremelimumab 1thymoglobulin 1pembrolizumab 1palifosfamide lysine 1isophosphamide mustard 1etoposide phosphate 1durvalumab 1cabazitaxel 1Vinblastine 1Stem Cell Transplantation 1Rituximab 1Radiotherapy 1Polymerase Chain Reaction 1Mycophenolic Acid 1Moxifloxacin 1Microarray Analysis 1Melphalan 1In Situ Hybridization 1Immunologic Techniques 1Immunohistochemistry 1Immunoenzyme Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Testicular Neoplasms × Gemcitabine × Clear all
NCT00531687 2017-10-03

Trial of Paclitaxel, Gemcitabine and Cisplatin in Patients With Relapsing Germ Cell Cancer

Rigshospitalet, Denmark

Phase 2 Terminated
8 enrolled
Genitourinary

Recurrence, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡